Zevra Therapeutics Inc. (ZVRA)
NASDAQ: ZVRA
· Real-Time Price · USD
10.01
0.73 (7.87%)
At close: Aug 21, 2025, 11:33 AM
Zevra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 25.88M | 20.4M | 12.04M | 3.69M | 4.45M | 3.42M | 13.22M | 2.9M | 8.47M | 2.88M | 2.32M | 2.87M | 1.3M | 3.96M | 2.58M | 1.97M | 11.99M | 12.12M |
Cost of Revenue | 12.38M | 1.34M | 1.37M | 2.3M | 3.57M | 3.27M | 2.79M | 144K | 677K | 125K | 143K | 141K | 51K | 8K | 59K | n/a | 1M | 1M |
Gross Profit | 13.5M | 19.06M | 10.68M | 1.39M | 876K | 160K | 10.43M | 2.75M | 7.79M | 2.75M | 2.18M | 2.73M | 1.25M | 3.96M | 2.52M | 1.97M | 10.99M | 11.12M |
Operating Income | -71.04M | -5.36M | -15.42M | -27.31M | -23.8M | -20.49M | -14.67M | -15.36M | -6.64M | -12.92M | 9.17M | -6.63M | -7.1M | -1.86M | -2.84M | -2.22M | 5.83M | 6.96M |
Interest Income | n/a | n/a | -73K | 1.05M | 270K | 929K | 208K | 1.74M | 1.55M | 1.04M | 590K | 218K | 366K | 107K | 112K | 137K | n/a | 8K |
Pretax Income | 76.91M | -1.92M | -20.37M | -33.23M | -19.86M | -16.69M | -15.15M | -10.19M | -5.16M | -11.87M | -9.05M | -6.65M | -24.76M | -1.87M | -2.67M | -1.76M | 6.2M | -10.3M |
Net Income | 74.71M | -3.1M | -35.74M | -33.23M | -19.93M | -16.62M | -15.15M | -10.37M | -5.08M | -11.77M | -9.02M | -6.62M | -24.04M | -1.86M | -2.7M | -1.76M | 6.2M | -10.3M |
Selling & General & Admin | 20.78M | 19.55M | 16.13M | 16.21M | 12.6M | 9.93M | 14.66M | 5.82M | 7M | 6.83M | 5.08M | 3.97M | 3.56M | 2.73M | 2.56M | 1.95M | 2.31M | 1.89M |
Research & Development | 3.43M | 3.26M | 9.91M | 10.95M | 10.52M | 10.71M | 10.45M | 12.3M | 7.43M | 8.84M | -11.31M | 5.38M | 4.79M | 3.08M | 2.81M | 2.24M | 2.85M | 2.27M |
Other Expenses | n/a | 1.61M | 54K | 1.54M | 1.55M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 24.21M | 24.42M | 26.09M | 28.7M | 24.67M | 20.65M | 25.1M | 18.11M | 14.44M | 15.68M | -6.23M | 9.36M | 8.35M | 5.82M | 5.37M | 4.19M | 5.15M | 4.16M |
Interest Expense | 2.01M | -1.97M | 2.19M | 1.26M | 2.11M | 735K | 756K | 366K | 197K | 182K | 18K | 124K | 36K | 5K | 5K | 6K | 25K | 349K |
Selling & Marketing Expenses | n/a | n/a | 14.52M | n/a | 11M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.21M | 25.76M | 27.46M | 31M | 28.24M | 23.91M | 27.89M | 18.26M | 15.12M | 15.8M | -6.09M | 9.5M | 8.4M | 5.82M | 5.42M | 4.19M | 6.15M | 5.16M |
Income Tax Expense | 2.2M | -1.18M | 15.37M | n/a | 70K | -70K | n/a | 177K | -74K | -103K | -34K | -33K | -715K | -4K | 34K | 6K | -39K | n/a |
Shares Outstanding (Basic) | 54.78M | 54.1M | 53.67M | 47.81M | 41.9M | 41.78M | 37.9M | 34.72M | 33.9M | 34.47M | 34.51M | 34.49M | 34.45M | 34.51M | 35.35M | 35.22M | 29.17M | 19.15M |
Shares Outstanding (Diluted) | 56.32M | 54.1M | 53.67M | 47.81M | 41.9M | 41.78M | 37.9M | 34.72M | 33.9M | 34.47M | 34.51M | 34.49M | 34.45M | 34.51M | 35.35M | 35.22M | 29.17M | 19.15M |
EPS (Basic) | 1.36 | -0.06 | -0.67 | -0.69 | -0.48 | -0.4 | -0.4 | -0.3 | -0.15 | -0.34 | -0.26 | -0.19 | -0.7 | -0.05 | -0.08 | -0.05 | 0.21 | -0.54 |
EPS (Diluted) | 1.21 | -0.06 | -0.67 | -0.69 | -0.48 | -0.4 | -0.4 | -0.3 | -0.15 | -0.34 | -0.26 | -0.19 | -0.7 | -0.05 | -0.08 | -0.05 | 0.21 | -0.54 |
EBITDA | -71.04M | 1.7M | -16.53M | -29.3M | -16.18M | -14.39M | -13.88M | -13.44M | -4.88M | -12.75M | -8.74M | -6.13M | -24.54M | -1.8M | -2.6M | -1.69M | 5.9M | -9.88M |
EBIT | 78.92M | 52K | -18.17M | -30.91M | -17.75M | -15.96M | -14.67M | -13.5M | -4.96M | -13.14M | -9.04M | -6.53M | -24.72M | -1.86M | -2.66M | -1.75M | 6.23M | -9.95M |
Depreciation & Amortization | 1.65M | 1.65M | 1.65M | 1.62M | 1.56M | 1.56M | 787K | 62K | 78K | 79K | 300K | 398K | 181K | 65K | 64K | 65K | 64K | 64K |